Evidence map›Paper›PMID 37430275›Full record

ArticleBMC pulmonary medicine2023

Etiology and clinical characteristics of a non-cystic fibrosis bronchiectasis cohort in a middle eastern population.

Irfan Shafiq, Ali Saeed Wahla, Mateen Haider Uzbeck, Zaid Zoumot, Mohamed Abuzakouk, Shuayb Elkhalifa, Govinda Bodi, Khalaf Mohamed Almazrouei, Kashyap Bodi, Said Isse

Open access · goldAbstract read
In one paragraph

Article in BMC pulmonary medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Epidemiology of bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Irfan ShafiqCleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates. irfanshafiq@gmail.com.
Ali Saeed WahlaCleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Mateen Haider UzbeckCleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Zaid ZoumotCleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Mohamed AbuzakoukCleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Shuayb ElkhalifaCleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Govinda BodiCleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Khalaf Mohamed AlmazroueiCleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Kashyap BodiCleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Said IsseCleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Abu Dhabi Health Services · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBronchiectasis is a widely prevalent airway disease characterized by airway dilatation and recurrent infections, that can lead to respiratory failure in severe cases. The etiology of bronchiectasis varies geographically, but there is a lack of published data examining its etiology specifically within the Middle Eastern population.

methodsWe conducted a retrospective analysis of our bronchiectasis patient registry, extracting clinical and demographic characteristics from electronic medical records. Quantitative variables were presented as the median and interquartile range (IQR), while categorical variables were expressed as numbers and percentages. Statistical comparisons for continuous characteristics were performed using the t-test, and significance was determined by a p-value less than 0.05.

resultsIn total we analysed 260 records (63% female, 37% male), with median age of 58 years (interquartile range (IQR) 38-71), Body Mass Index (BMI) 25.8(IQR 22-30), forced expiratory volume in the first second (FEV1) %predicted 65 (IQR 43-79) and FEV1/forced vital capacity (FVC) 0.76 (0.67-0.86). Sixty-five cases (25%) were post-infectious in aetiology (excluding post-TB - n:27 10.4%). Forty-eight (18.5%) patients were labelled idiopathic, while Primary Ciliary Dyskinesia (PCD) accounted for 23 (8.8%) cases. Pseudomonas aeruginosa was the most common colonizing organism (32.7%), followed by Haemophilus influenzae (9.2%) and Methicillin-Sensitive Staphylococcus aureus(6.9%). At the time of review, 11 patients had died (median age, FEV %predicted, and bronchiectasis severity index (BSI) 59 years, 38% and 15.5 respectively), all due to respiratory failure, and as expected, all were classed severe on BSI. The BSI score was available for 109 patients, of which 31(28%) were classed mild, 29(27%) were moderate, and 49 (45%) were classed severe. The median BSI score was 8 (IQR 4-11). On dividing the patients according to obstructive vs. restrictive spirometry, we found that patients with FEV1/FVC < 0.70 had significantly higher BSI (10.1 vs. 6.9, p-value < 0.001) and that 8 out of the 11 deceased patients had FEV1/FVC < 70%.

conclusionsIn our study, post-infectious, idiopathic, and PCD were identified as the most common etiologies of bronchiectasis. Additionally, patients with obstructive spirometry appeared to have a worse prognosis compared to those with restrictive spirometry.

Indexed as

BronchiectasisBody Mass IndexElectronic Health RecordsFemaleForced Expiratory VolumeHumansMaleMiddle AgedRetrospective StudiesAetiologyBronchiectasisObstructive lung diseasePost-infectious

Identifiers

PMID37430275
PMCPMC10334600
OpenAlexW4383815980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.